Test Price
2,800 AED✅ Home Collection Available
GP9 Gene Bernard Soulier Syndrome, Type C Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين GP9 لمتلازمة برنارد-سولييه النوع C في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
🏥 UAE Clinical Guarantee: Precision, Privacy & Compassion
- ✓99.9% Diagnostic Sensitivity – NGS‑based detection of all pathogenic GP9 variants, validated under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
- ✓Premium Home‑Collection & Cold‑Chain Logistics – Hospital‑grade VIP phlebotomy in Dubai, Abu Dhabi, Sharjah & all Northern Emirates; ISO‑certified temperature‑controlled transport for DNA stability.
- ✓Post‑Test Clinical Guidance – Complimentary 15‑minute tele‑consultation with a DHA‑licensed genetic counsellor to interpret your results and plan next steps.
- ✓Insurance & Direct Billing – Verify your coverage instantly via WhatsApp +971 54 548 8731.
- ✓Turnaround Time: 3–4 weeks from sample arrival at our Dubai laboratory.
All services strictly adhere to UAE Federal Decree‑Law No. 41 of 2024 (Art. 87), the CDS Law 2026 for minors, and the UAE Personal Data Protection Law (PDPL).
Clinical Overview & Technology Edge
GP9 Gene Bernard Soulier Syndrome, Type C Genetic Test is a definitive molecular assay that identifies pathogenic variants in the GP9 gene causing autosomal recessive Bernard‑Soulier syndrome – a severe platelet disorder. Our test utilizes Next‑Generation Sequencing (NGS) with full transcriptome/RNA sequencing integration to deliver near‑perfect sensitivity.
تحليل جيني شامل يكشف الطفرات المسببة لمتلازمة برنارد‑سولييه النوع C عبر تقنية التسلسل فائق الدقة، ويتضمن استشارة وراثية معتمدة من هيئة الصحة بدبي.
| Feature | Our Test (DHA‑Approved) | Closest Alternative |
|---|---|---|
| Methodology | NGS + RNA Sequencing (full gene coverage) | Sanger sequencing of select exons only |
| Variant Detection | SNVs, indels, copy‑number changes, splicing mutations – 99.9% analytic sensitivity | Point mutations & small indels; CNVs often missed |
| Turnaround Time | 3–4 weeks (prioritised for urgent clinical need) | 6–8 weeks |
| Clinical Support | Pre‑ & post‑test genetic counselling included | Report only, no tele‑guidance |
| Regulatory Body | DHA‑licensed facility (License: 9834453), ISO 9001:2015 | May lack UAE‑specific accreditation |
👨⚕️ Physician Insight & Safety Protocol
“Understanding your genetic risk for a bleeding disorder can be daunting. This NGS test provides you and your clinician with a powerful map of the GP9 gene, but it doesn’t replace a thorough bleeding history and platelet function assessment. You are not alone – our genetic counselling team will walk you through each finding, ensuring you feel supported and informed at every step.”
— Dr. Prabhakar Reddy, DHA‑Licensed Consultant (License: 61713011)
⚠️ Medication Warning: Do not discontinue or modify any prescribed medication, especially antiplatelet agents or anticoagulants, without direct consultation with your treating physician. This test alone cannot guide acute management.
🚨 Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide informed consent; active severe illness that prevents safe blood collection; known unavailability of a competent adult to receive results.
- Red Flags – Seek ER Care Immediately: Sudden severe bleeding (nose, gums, urine, gastrointestinal), heavy menstrual bleeding with dizziness, or signs of intracranial haemorrhage (severe headache, confusion, loss of consciousness).
- Post‑Test Caveat: A negative result does not rule out other platelet disorders; clinical correlation is mandatory.
Frequently Asked Questions – Direct Clinical Answers
Q1: What does the GP9 gene test diagnose, and why do I need it?
Snippet‑worthy answer: This NGS test identifies disease‑causing mutations in the GP9 gene responsible for autosomal recessive Bernard‑Soulier syndrome type C, a lifelong platelet disorder. It confirms the diagnosis in symptomatic patients with prolonged bleeding, giant platelets, and thrombocytopenia, and it enables carrier testing for family planning. Accurate genetic confirmation is essential for tailored management and to avoid misdiagnosis as immune thrombocytopenia.
يُشخِّص هذا التحليل الطفرات المسببة لمتلازمة برنارد‑سولييه النوع C، وهو ضروري للمرضى الذين يعانون من نزيف غير مبرر وتضخم الصفائح الدموية، ولأقاربهم من حاملي الجين.
Q2: How is the sample collected, and is a home visit available in my emirate?
Snippet‑worthy answer: A small volume of whole blood (3‑5 mL in EDTA), extracted DNA, or a single drop of blood on an FTA card is all that is required for this. Our VIP home‑collection service operates daily from 8 AM to 11 PM across all seven emirates, with ISO‑certified cold‑chain logistics preserving sample integrity until it reaches the sequencing facility.
يمكن جمع العينة في منزلك عبر خدمة فنيي المختبر المتنقلين، وهي متاحة في جميع الإمارات مع نقل مبرد وفق المعايير الدولية.
Q3: How reliable are the results, and what support do I get afterwards?
Snippet‑worthy answer: Our laboratory achieves 99.9% diagnostic sensitivity for the GP9 gene by combining NGS with RNA sequencing, a method that outperforms traditional Sanger sequencing. After the report is issued, you receive a complimentary tele‑consultation with a DHA‑licensed genetic counsellor who explains the clinical significance of each variant and guides you on next steps, including referral to a haematologist if indicated.
دقة التحليل تصل إلى 99.9%، ويصاحب التقرير استشارة وراثية هاتفية معتمدة من هيئة الصحة لشرح النتائج وتوجيهك للعلاج المناسب.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians